400 ATLANTIC STREET, SUITE 500, STAMFORD, CT
Market cap: $8.1M (4/14/2025)
Price: $5.32
Investor Presentation
Retention Compensation Approved for Executive Officers at Tvardi Therapeutics
Earnings Release
Provides Update on Preliminary Data from Phase 2 REVERT Trial in Idiopathic Pulmonary Fibrosis
Announces Second Quarter 2025 Results and Provides Business Update
Changes in Board, Management or Compensation
Other Events
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities to be Offered to Employees
Amended Registration Statement for Securities
S-1
Prospectus Filed Pursuant to Rule 425
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership